Update: Protective and risk factors for Parkinson disease
- PMID: 38879999
- PMCID: PMC11846500
- DOI: 10.1016/j.parkreldis.2024.107026
Update: Protective and risk factors for Parkinson disease
Abstract
We review the epidemiologic literature on potential protective and risk factors in Parkinson's Disease (PD). Prior research identified numerous possible protective and risk factors. Potential protective factors include tobacco abuse, physical activity, urate levels, NSAID use, calcium channel blocker use, statin use, and use of some α1-adrenergic antagonists. Some potential protective factors could be products of reverse causation, including increased serum urate, tobacco abuse, and coffee-tea-caffeine consumption. Potential risk factors include traumatic brain injury, pesticide exposure, organic solvent exposure, lead exposure, air pollution, Type 2 Diabetes, some dairy products, cardiovascular disease, and some infections including Hepatitis C, H. pylori, and COVID-19. Potential non-environmental risk factors include bipolar disorder, essential tremor, bullous pemphigoid, and inflammatory bowel disease. There is an inverse relationship with PD and risk of most cancers. Though many potential protective and risk factors for PD were identified, research has not yet led to unique, rigorous prevention trials or successful disease-modifying interventions. While efforts to reduce exposure to some industrial toxicants are well justified, PD incidence might be most effectively reduced by mitigation of risks, such as Type 2 Diabetes, air pollution, traumatic brain injury, or physical inactivity, that are general public health intervention targets.
Keywords: Epidemiology; Parkinson disease; Protection; Risk.
Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Roger Albin reports financial support was provided by National Institute of Neurological Disorders and Stroke. Roger Albin reports financial support was provided by Parkinson's Foundation. Roger Albin reports a relationship with Ionis Pharmaceuticals Inc that includes: consulting or advisory. Roger Albin reports a relationship with IQVIA that includes: consulting or advisory. Roger Albin reports a relationship with Biogen Inc that includes: consulting or advisory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The epidemiology of Parkinson's disease: risk factors and prevention.Lancet Neurol. 2016 Nov;15(12):1257-1272. doi: 10.1016/S1474-4422(16)30230-7. Epub 2016 Oct 11. Lancet Neurol. 2016. PMID: 27751556 Review.
-
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?Neurobiol Dis. 2020 Feb;134:104671. doi: 10.1016/j.nbd.2019.104671. Epub 2019 Nov 6. Neurobiol Dis. 2020. PMID: 31706021 Review.
-
Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews.J Parkinsons Dis. 2021;11(3):919-935. doi: 10.3233/JPD-202521. J Parkinsons Dis. 2021. PMID: 33814465 Free PMC article. Review.
-
Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese.J Neurol Sci. 2003 Dec 15;216(1):163-7. doi: 10.1016/j.jns.2003.07.006. J Neurol Sci. 2003. PMID: 14607318
-
Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.Am J Epidemiol. 2002 Apr 15;155(8):732-8. doi: 10.1093/aje/155.8.732. Am J Epidemiol. 2002. PMID: 11943691
Cited by
-
Exploring Risk and Protective Factors in Parkinson's Disease.Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710. Cells. 2025. PMID: 40422213 Free PMC article. Review.
References
-
- Ascherio A, Schwarzschild MA, The epidemiology of Parkinson’s disease: risk factors and prevention, Lancet Neurol. 15 (12) (2016) 1257–1272. - PubMed
-
- Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J, Pooled analysis of tobacco use and risk of Parkinson disease, Arch. Neurol 64 (7) (2007) 990–997. - PubMed
-
- Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ, A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease, Ann. Neurol 52 (3) (2002) 276–284. - PubMed
-
- Li X, Li W, Liu G, Shen X, Tang Y, Association between cigarette smoking and Parkinson’s disease: a meta-analysis, Arch. Gerontol. Geriatr 61 (3) (2015) 510–516. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical